Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Current treatment of T cell mediated autoimmune diseases relies mostly on strategies of global immunosuppression, which, in the long term, is accompanied by adverse side effects such as a reduced ability to control infections or malignancies. Therefore, new approaches need to be developed that targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Schütz, Christian, Fleck, Martin, Schneck, Jonathan P., Oelke, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MyJove Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710085/
https://www.ncbi.nlm.nih.gov/pubmed/25145915
http://dx.doi.org/10.3791/51859